1. Home
  2. CNTX vs UONE Comparison

CNTX vs UONE Comparison

Compare CNTX & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • UONE
  • Stock Information
  • Founded
  • CNTX 2015
  • UONE 1980
  • Country
  • CNTX United States
  • UONE United States
  • Employees
  • CNTX N/A
  • UONE N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • UONE Broadcasting
  • Sector
  • CNTX Health Care
  • UONE Consumer Discretionary
  • Exchange
  • CNTX Nasdaq
  • UONE Nasdaq
  • Market Cap
  • CNTX 77.2M
  • UONE 69.5M
  • IPO Year
  • CNTX 2021
  • UONE N/A
  • Fundamental
  • Price
  • CNTX $0.96
  • UONE $1.44
  • Analyst Decision
  • CNTX Strong Buy
  • UONE
  • Analyst Count
  • CNTX 5
  • UONE 0
  • Target Price
  • CNTX $6.70
  • UONE N/A
  • AVG Volume (30 Days)
  • CNTX 1.1M
  • UONE 24.1K
  • Earning Date
  • CNTX 11-06-2024
  • UONE 11-12-2024
  • Dividend Yield
  • CNTX N/A
  • UONE N/A
  • EPS Growth
  • CNTX N/A
  • UONE N/A
  • EPS
  • CNTX N/A
  • UONE N/A
  • Revenue
  • CNTX N/A
  • UONE $452,891,000.00
  • Revenue This Year
  • CNTX N/A
  • UONE N/A
  • Revenue Next Year
  • CNTX N/A
  • UONE N/A
  • P/E Ratio
  • CNTX N/A
  • UONE N/A
  • Revenue Growth
  • CNTX N/A
  • UONE N/A
  • 52 Week Low
  • CNTX $0.89
  • UONE $1.23
  • 52 Week High
  • CNTX $2.75
  • UONE $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 38.22
  • UONE 43.62
  • Support Level
  • CNTX $0.92
  • UONE $1.47
  • Resistance Level
  • CNTX $1.05
  • UONE $1.64
  • Average True Range (ATR)
  • CNTX 0.13
  • UONE 0.09
  • MACD
  • CNTX 0.01
  • UONE -0.01
  • Stochastic Oscillator
  • CNTX 17.78
  • UONE 8.04

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: